Ketoprofene Cristers Lp

Ketoprofen, the active ingredient in Ketoprofene Cristers Lp, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is employed to relieve mild to moderate pain and to manage inflammatory conditions such as rheumatoid arthritis, osteoarthritis and other musculoskeletal disorders.

GNH USA supplies Ketoprofene Cristers Lp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes.

- Rheumatoid arthritis: decreases joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Musculoskeletal pain: provides relief from strains, sprains, back pain and other soft‑tissue injuries.

Ketoprofen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: dyspepsia, nausea or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or pruritus. - Elevated liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal impairment or failure. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatic dysfunction or hepatitis. - Anaphylactic or severe allergic reactions.

When prescribing or dispensing Ketoprofene Cristers Lp, consider the following safety measures.

- Assess renal function: avoid or adjust use in patients with significant renal impairment. - Monitor gastrointestinal health: contraindicated in active peptic ulcer disease or recent GI bleeding. - Avoid concomitant anticoagulants: increased risk of serious bleeding. - Use caution in cardiovascular disease: NSAIDs may elevate blood pressure and cardiovascular events. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Ketoprofen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Selective COX‑2 inhibitors (e.g., celecoxib): additive gastrointestinal and renal toxicity. - Lithium: increased serum lithium concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Diuretics: potential for renal impairment and electrolyte disturbances. - Methotrexate: reduced clearance leading to toxicity.